The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: The 2017 Revision and Update

Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO

Research output: Contribution to journalArticle

Abstract

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

Original languageEnglish
Pages (from-to)1393-1414
Number of pages22
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume73
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Urticaria
Dermatology
Allergy and Immunology
Hypersensitivity
Asthma
Organizations
Guidelines
Mastocytosis
Angioedema
European Union
Quality of Life

Keywords

  • angioedema
  • consensus
  • evidence-based
  • hives
  • wheal

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO (2018). The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: The 2017 Revision and Update. Allergy: European Journal of Allergy and Clinical Immunology, 73(7), 1393-1414. https://doi.org/10.1111/all.13397

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria : The 2017 Revision and Update. / Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, No. 7, 01.07.2018, p. 1393-1414.

Research output: Contribution to journalArticle

Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO 2018, 'The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: The 2017 Revision and Update', Allergy: European Journal of Allergy and Clinical Immunology, vol. 73, no. 7, pp. 1393-1414. https://doi.org/10.1111/all.13397
Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: The 2017 Revision and Update. Allergy: European Journal of Allergy and Clinical Immunology. 2018 Jul 1;73(7):1393-1414. https://doi.org/10.1111/all.13397
Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. / The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria : The 2017 Revision and Update. In: Allergy: European Journal of Allergy and Clinical Immunology. 2018 ; Vol. 73, No. 7. pp. 1393-1414.
@article{7ef12dc6606e45eabc911fcee7e5a3ef,
title = "The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: The 2017 Revision and Update",
abstract = "This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20{\%}. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.",
keywords = "angioedema, consensus, evidence-based, hives, wheal",
author = "{Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, {\"O}GDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO} and T. Zuberbier and W. Aberer and R. Asero and {Abdul Latiff}, {A. H.} and D. Baker and B. Ballmer-Weber and Bernstein, {J. A.} and C. Bindslev-Jensen and Z. Brzoza and {Buense Bedrikow}, R. and Canonica, {G. W.} and Church, {M. K.} and T. Craig and Danilycheva, {I. V.} and C. Dressler and Ensina, {L. F.} and A. Gim{\'e}nez-Arnau and K. Godse and M. Gon{\cc}alo and C. Grattan and J. Hebert and M. Hide and A. Kaplan and A. Kapp and Katelaris, {C. H.} and E. Kocat{\"u}rk and K. Kulthanan and D. Larenas-Linnemann and Leslie, {T. A.} and M. Magerl and P. Mathelier-Fusade and Meshkova, {R. Y.} and M. Metz and A. Nast and E. Nettis and H. Oude-Elberink and S. Rosumeck and Saini, {S. S.} and M. S{\'a}nchez-Borges and P. Schmid-Grendelmeier and P. Staubach and G. Sussman and E. Toubi and Vena, {G. A.} and C. Vestergaard and B. Wedi and Werner, {R. N.} and Z. Zhao and M. Maurer",
year = "2018",
month = "7",
day = "1",
doi = "10.1111/all.13397",
language = "English",
volume = "73",
pages = "1393--1414",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

T2 - The 2017 Revision and Update

AU - Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI,

AU - Zuberbier, T.

AU - Aberer, W.

AU - Asero, R.

AU - Abdul Latiff, A. H.

AU - Baker, D.

AU - Ballmer-Weber, B.

AU - Bernstein, J. A.

AU - Bindslev-Jensen, C.

AU - Brzoza, Z.

AU - Buense Bedrikow, R.

AU - Canonica, G. W.

AU - Church, M. K.

AU - Craig, T.

AU - Danilycheva, I. V.

AU - Dressler, C.

AU - Ensina, L. F.

AU - Giménez-Arnau, A.

AU - Godse, K.

AU - Gonçalo, M.

AU - Grattan, C.

AU - Hebert, J.

AU - Hide, M.

AU - Kaplan, A.

AU - Kapp, A.

AU - Katelaris, C. H.

AU - Kocatürk, E.

AU - Kulthanan, K.

AU - Larenas-Linnemann, D.

AU - Leslie, T. A.

AU - Magerl, M.

AU - Mathelier-Fusade, P.

AU - Meshkova, R. Y.

AU - Metz, M.

AU - Nast, A.

AU - Nettis, E.

AU - Oude-Elberink, H.

AU - Rosumeck, S.

AU - Saini, S. S.

AU - Sánchez-Borges, M.

AU - Schmid-Grendelmeier, P.

AU - Staubach, P.

AU - Sussman, G.

AU - Toubi, E.

AU - Vena, G. A.

AU - Vestergaard, C.

AU - Wedi, B.

AU - Werner, R. N.

AU - Zhao, Z.

AU - Maurer, M.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

AB - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

KW - angioedema

KW - consensus

KW - evidence-based

KW - hives

KW - wheal

UR - http://www.scopus.com/inward/record.url?scp=85048001207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048001207&partnerID=8YFLogxK

U2 - 10.1111/all.13397

DO - 10.1111/all.13397

M3 - Article

AN - SCOPUS:85048001207

VL - 73

SP - 1393

EP - 1414

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 7

ER -